INTRODUCTION
The crucial role of D-myo-inositol-1 ,4,5-trisphosphate [Ins (1, 4, 5 )P3] as a second messenger acting by initiating intracellular Ca2l mobilization is well recognized [1] [2] [3] . In the cytosol, Ins(1,4,5)P3 and its metabolites undergo rapid metabolism by sequential actions of phosphatases and kinases, generating a plethora of endogenous inositol phosphates [4] . Although the intracellular distribution and biological roles of most of these congeners remain unclear, the rich diversity of phosphoinositols generated from such a complex metabolic network implies the physiological relevance of these compounds. A body ofevidence indicates that some ofthese inositol phosphate metabolites are capable of eliciting Ca2l release by interacting with the Ins(1,4,5)P3 receptor, albeit at lower potencies [5] [6] [7] [8] [9] . These include Ins (1, 3, 4, 6) P4, Ins(1I,3,4,5)P4, Ins(1,4,5,6)P4 and Ins(4,5)P2. One school ofthought is that these inositol phosphates exert a concerted effort to maintain Ca2l oscillations in the course of signal transduction. Alternatively, one may argue that the Ca2+-mobilizing activity of these polyphosphates is coincidental, due to the sharing ofcommon structural motifs. Evidently, these two theories bear vastly different implications in the context of intracellular Ca2+ signalling and warrant close examination.
To address this issue, one of our strategies is to develop specific antibodies against inositol phosphates, particularly Ins(1I,4,5)P3
as biochemical probes. In the literature, antibodies to Ptdlns and Ptdlns(4,5)P2 have been prepared through immunizing animals with the corresponding phospholipids [10] MATERIALS AND METHODS
were used for the preparation of InsP3-C6NC5-BSA and InsP3-C5-BSA, respectively ( Figure  1 ), of which the synthesis has been reported elsewhere [15] . IP3-Cs-BSA was then added and the incubation continued at room temperature for an additional 2 h. The reaction mixture was dialysed against 15 mM NaHCO./CO2 buffer, pH 7.4, overnight, and lyophilized to give InsP.-C,-BSA.
New Zealand White female rabbits were immunized with 1 mg of the InsP3-BSA conjugate in 0.5 ml of saline emulsified with an equal volume of Freund's complete adjuvant by multiple subcutaneous injections into the back and both flanks. Booster injections were given, at monthly intervals, with the same amounts of the InsP,-BSA prepared with incomplete Freund's adjuvant. After the second boost, the animals were bled from the ear vein 2 weeks after each booster injection. The antisera thus prepared were stored at -20°C until required for use.
ELISA
The presence of anti-Ins(1,4,5)P3 antibodies in rabbit serum was detected by an ELISA. Ins(1,4,5)P3 was covalently attached to microtitre plates through a C-6 linker by adding (-)-1 (1.25 ,tg in 0.1 ml of PBS per well) to maleic anhydride-activated polystyrene plates (Pierce). This anhydride-activated plate allows direct coupling of amine-bearing molecules to the well surface [18] , and obviates the need for a carrier protein to immobilize the hapten. After overnight incubation at room temperature, the plate was decanted, and each well was blocked by adding 0.12 ml of the SuperBlock blocking solution prepared in PBS (Pierce). After 10 min at room temperature, the plate was washed twice with TBS (0.05 % Tween-20 in 10 mM Tris/HCl containing 0.85 % NaCl, pH 7.2), followed by two further washes in TBS buffer. Rabbit antiserum diluted in TBS buffer (200-300-fold) containing 0. After 2-3 sets of booster injections, one of the rabbits immunized with InsP3-C6NC5-BSA and the rabbit receiving InsP3-C5-BSA were found to produce antibodies against Ins(l,4,5)P3, both ofwhich showed similar titres of about 1:4000. This antibody formation seemed to be independent of the spacer length and InsP3 content. The antibody titres increased only moderately in both rabbits after subsequent booster injections. It appeared that the remaining two rabbits that received InsP3-CNC5-BSA immunization generated antibodies predominantly directed against the C6NC5-linker.
The avidity and specificity of these antisera were examined by a competitive ELISA between immobilized Ins(1,4,5)P3 and various inositol phosphates. As indicated from the concentrations at half-maximal absorbance (B/Bo = 0.5) or IC50 (Table 1) The recognition of inositol phosphates by the InsP3-C5-BSAinduced antiserum qualitatively paralleled that aforementioned (Table 1) . However, the latter antibodies exhibited higher affinity for Ins(1,4,5)P3 and Ins(1,3,4,5)P4 and a 10-fold decrease in affinity with Ins(1,3,4)P3.
Although both antisera were highly specific for Ins(1,4,5)P3, they also cross-reacted with Ins (1,3,4,5 Three New Zealand rabbits were immunized with InsP3-C6NC5- The column was washed with the equilibrating buffer followed by, in sequence, (A) 15 ml of 500 mM NaCI in the same buffer; (B) 30 ml of 100 mM glycine buffer,pH 3.5; (C) 15 ml of 10 mM Tris buffer, pH 8.8; and (D) 35 ml of 100 mM NaHCO3/Na2CO3 buffer, pH 10.5. Fractions of 1.7 ml were collected in tubes containing 100 ,ul of 1 M Tris/HCI buffer, pH 8.0. Fractions 66-69, exhibiting anti-lns(1,4,5)P3 antibody activity, were pooled, concentrated, and dialysed against 10 mM Tris buffer, pH 7.5.
Purification of the lns(1,4,5)P3-specrfJc antibody
The level of discrimination between Ins(1,4,5)P3 and Ins(1,3,4,5)P4 by these antisera appeared to be lower than that reported for Ins(1,4,5)P3 receptors [8, 19] . The lack of specificity could be attributed to the heterogeneity in the antigen-binding sites, which prompted us to subject the InsP3-C5-BSA-induced antiserum to chromatographic purification on immobilized Protein A and Ins(1,4,5)P3-agarose (Figures 2a and 2b) . The utility of the InsP3 affinity column is especially noteworthy. The Ins(1,4,5)P3-specific antibody showed strong binding with the affinity matrix, and could only be eluted under alkaline conditions. [20, 21] . The three phosphate functions of the immobilized Ins(1,4,5)P3 are freely exposed, enabling optimal interaction with the binding proteins to occur. As a result, the degree of discrimination among various inositol phosphates by the affinity-purified antibody (Figure 3) was comparable with that of the Ins(1,4,5)P3 receptor. For example, in the competitive ELISA assay, the IC50 value for Ins(l,3,4,5)P4 was 60-fold higher than that of Ins(l,4,5)P3, which is similar to that reported for the receptor binding [8, 19] . However, it is worthy of note that the modes of ligand recognition at the binding sites of these two types of biomolecules are somewhat different.
Since the ligand binding arises from complementary interactions involving ion painrng and hydrogen bonding between the antigen-binding domain and the hapten, the binding could be disrupted by a number of unrelated multivalent anions such as ATP4-, HP042-or S042-at high concentrations, whereas no significant inhibition was observed with monovalent ions. As indicated from the concentration spans for complete inhibition (Figure 4) , these multivalent anions bound to and neutralized the charges of basic amino acid residues inside the InsP3 binding domain in a non-specific manner. This inhibition is noteworthy because use of any of these anions during the antibody preparation or immunoassay would lead to loss of the antibody activity. In our study, attempts to enrich the antibodies using (NH4)2S04 precipitation resulted in a complete loss of binding activity even after extensive dialysis. In the literature, inhibition of ligand binding by multivalent anions has also been reported for Ins(1,4,5)P3 receptors. The antagonistic effects of heparin, decavanadate, nucleotides and phosphate at the Ins(1,4,5)P3 binding site is well understood [22] [23] [24] [25] [26] [27] . However, unlike Ins(1,4,5)P3 receptors, the binding of the ligand to the antibody was not affected by heparin up to 0.3 mM. Moreover, cations such as Tris, K+, Na+, etc. did not cause any inhibition.
A technical point worth mentioning concerns the ELISA developed in this study. In our initial experiments, InsP3--C6NC.-asein, prepared in a manner similar to that described for the BSA counterpart, was coated to regular microtitre plates through adsorption. These plates failed to capture anti-InsP3 antibodies, and did not respond to competitive binding experiments by free InsP3 in a concentration-dependent fashion. This lack of specific binding may be attributed to (a) the presence of antibodies directed against the C6NC5-linker, and/or (b) the lack of adsorption of InsP3-C6NC5-casein to the polystyrene surface due to the high charge density of the InsP3 moiety. As a result, the InsP3-immobilized microtitre plates were used to circumvent these interferences.
The utility of the anti-Ins(1,4,5)P3 antibody is 2-fold. First, the ELISA developed here provides a sensitive, quantitative analysis of Ins(1,4,5)P3 along with many other advantages compared with the radioligand-binding assay. The detection limit of this assay was in the range of picograms. Secondly, antibodies directed against phosphatidylinositol and PtdInsP2 have been applied to probing the intracellular transduction mechanism in various types of cells involving PtdInsP2 as a second-messenger precursor [10, 13, 28, 29] . This anti-Ins(l,4,5)P3 antibody will add a new line of biological probes for examining the actions of Ins(1,4,5)P3 and its metabolites. Examinations of these potential applications with the anti-Ins(l,4,5)P3 antibody are currently underway in this laboratory.
